As of Nov 25
| -0.04 / -1.22%|
The 1 analysts offering 12-month price forecasts for CORPORATION PHARMACEUTIQUE NYMOX have a median target of 9.00, with a high estimate of 9.00 and a low estimate of 9.00. The median estimate represents a +176.92% increase from the last price of 3.25.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.